Joel R. Rathbun - Aug 7, 2024 Form 4 Insider Report for AVIENT CORP (AVNT)

Signature
/s/ Robert K. James, Power of Attorney For: Joel R. Rathbun
Stock symbol
AVNT
Transactions as of
Aug 7, 2024
Transactions value $
-$568,172
Form type
4
Date filed
8/9/2024, 01:13 PM
Previous filing
Feb 26, 2024
Next filing
Nov 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNT Common Stock Options Exercise $95.7K +2.5K +29.98% $38.27 10.8K Aug 7, 2024 Direct
transaction AVNT Common Stock Disposed to Issuer -$99.6K -2.29K -21.08% $43.58 8.56K Aug 7, 2024 Direct
transaction AVNT Common Stock Options Exercise $260K +10.4K +121.57% $24.98 19K Aug 7, 2024 Direct
transaction AVNT Common Stock Disposed to Issuer -$317K -7.26K -38.29% $43.66 11.7K Aug 7, 2024 Direct
transaction AVNT Common Stock Sale -$507K -11.7K -100% $43.36 0 Aug 7, 2024 Direct F1
holding AVNT Common Stock 28.4K Aug 7, 2024 Supplemental Plan F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVNT Stock Appreciation Rights Options Exercise $0 -2.5K -100% $0.00* 0 Aug 7, 2024 Common Stock 2.5K $38.27 Direct F3
transaction AVNT Stock Appreciation Rights Options Exercise $0 -10.4K -100% $0.00* 0 Aug 7, 2024 Common Stock 10.4K $24.98 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.21 to $43.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F2 The information in this report is based on a plan statement as of August 7, 2024.
F3 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $38.27 per share and no more than one-third of the grant can vest per year during the first three years.
F4 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $24.98 per share and no more than one-third of the grant can vest per year during the first three years.